Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08XQA
|
||||
| Former ID |
DIB004287
|
||||
| Drug Name |
RSD-921
|
||||
| Synonyms |
PD 123497
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Anesthesia [ICD9: 338; ICD10:R20.0] | Discontinued in Phase 2 | [546121] | ||
| Company |
University of British Columbia
|
||||
| Formula |
C21H28N2OS
|
||||
| Canonical SMILES |
C(=O)(N([C@H]1[C@H](N2CCCC2)CCCC1)C)Cc1c2c(scc2)ccc1
|
||||
| CAS Number |
CAS 114419-77-1
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Modulator | [525513] | |
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.